Neuroleptic malignant syndrome in cycloserine-induced psychosis
Sawant, Neena S.
Neuroleptic malignant syndrome in cycloserine-induced psychosis - Vol.47(3), May-Jun - Mumbai Wolter Kluwer 2015 - 328-329p.
A 33-year-old multidrug-resistant tuberculosis female patient diagnosed as cycloserine-induced psychosis developed several neuroleptic side effects such as extrapyramidal reaction, neuroleptic malignant syndrome, and drug-induced parkinsonism while she was being treated with initially haloperidol and then olanzapine over a period of 2 months. Patient's antipsychotic medications were withdrawn, and treatment with bromocriptine showed prompt recovery. The multiple neurological adverse effects which the patient developed had implications on the management of the complications as well as her illness.
PHARMACOLOGY
Neuroleptic malignant syndrome in cycloserine-induced psychosis - Vol.47(3), May-Jun - Mumbai Wolter Kluwer 2015 - 328-329p.
A 33-year-old multidrug-resistant tuberculosis female patient diagnosed as cycloserine-induced psychosis developed several neuroleptic side effects such as extrapyramidal reaction, neuroleptic malignant syndrome, and drug-induced parkinsonism while she was being treated with initially haloperidol and then olanzapine over a period of 2 months. Patient's antipsychotic medications were withdrawn, and treatment with bromocriptine showed prompt recovery. The multiple neurological adverse effects which the patient developed had implications on the management of the complications as well as her illness.
PHARMACOLOGY